 | • レポートコード：MRC2312MG06424 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、61ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界のサル痘治療薬市場規模と予測を収録しています。・世界のサル痘治療薬市場：売上、2018年-2023年、2024年-2029年 ・世界のサル痘治療薬市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のサル痘治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「経口剤」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 サル痘治療薬のグローバル主要企業は、Bavarian Nordic、 Chimerix, Inc.、 CIDIC Company Limited、 Emcure Pharmaceuticals、 Emergent、 Gilead Sciences Inc.、 Hetero Drugs Limited、 Jinan Jinda Pharmaceutical Chemistry Co. Ltd.、 Mylan N.V.、 Olon S.p.A.、 Piramal Pharma Solutions、 SIGA Technologies Inc.、 Sonofi SA、 Teva Pharmaceutical Industries Limitedなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、サル痘治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のサル痘治療薬市場：タイプ別、2018年-2023年、2024年-2029年 世界のサル痘治療薬市場：タイプ別市場シェア、2022年 ・経口剤、注射剤 世界のサル痘治療薬市場：用途別、2018年-2023年、2024年-2029年 世界のサル痘治療薬市場：用途別市場シェア、2022年 ・病院薬局、オンライン薬局、小売薬局 世界のサル痘治療薬市場：地域・国別、2018年-2023年、2024年-2029年 世界のサル痘治療薬市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるサル痘治療薬のグローバル売上、2018年-2023年 ・主要企業におけるサル痘治療薬のグローバル売上シェア、2022年 ・主要企業におけるサル痘治療薬のグローバル販売量、2018年-2023年 ・主要企業におけるサル痘治療薬のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Bavarian Nordic、 Chimerix, Inc.、 CIDIC Company Limited、 Emcure Pharmaceuticals、 Emergent、 Gilead Sciences Inc.、 Hetero Drugs Limited、 Jinan Jinda Pharmaceutical Chemistry Co. Ltd.、 Mylan N.V.、 Olon S.p.A.、 Piramal Pharma Solutions、 SIGA Technologies Inc.、 Sonofi SA、 Teva Pharmaceutical Industries Limited ************************************************************* ・調査・分析レポートの概要 サル痘治療薬市場の定義 市場セグメント 世界のサル痘治療薬市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のサル痘治療薬市場規模 世界のサル痘治療薬市場規模：2022年 VS 2029年 世界のサル痘治療薬市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのサル痘治療薬の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のサル痘治療薬製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：経口剤、注射剤 サル痘治療薬のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院薬局、オンライン薬局、小売薬局 サル痘治療薬の用途別グローバル売上・予測 ・地域別市場分析 地域別サル痘治療薬市場規模 2022年と2029年 地域別サル痘治療薬売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Bavarian Nordic、 Chimerix, Inc.、 CIDIC Company Limited、 Emcure Pharmaceuticals、 Emergent、 Gilead Sciences Inc.、 Hetero Drugs Limited、 Jinan Jinda Pharmaceutical Chemistry Co. Ltd.、 Mylan N.V.、 Olon S.p.A.、 Piramal Pharma Solutions、 SIGA Technologies Inc.、 Sonofi SA、 Teva Pharmaceutical Industries Limited ... |
This research report provides a comprehensive analysis of the Monkeypox Treatment market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Monkeypox Treatment market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Monkeypox Treatment, challenges faced by the industry, and potential opportunities for market players.
The global Monkeypox Treatment market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Monkeypox Treatment market presents opportunities for various stakeholders, including Hospital Pharmacy, Online Pharmacy. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Monkeypox Treatment market. Additionally, the growing consumer demand present avenues for market expansion.
The global Monkeypox Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Monkeypox Treatment market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Monkeypox Treatment market.
Market Overview: The report provides a comprehensive overview of the Monkeypox Treatment market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Oral, Injectable), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Monkeypox Treatment market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Monkeypox Treatment market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Monkeypox Treatment market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Monkeypox Treatment market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Monkeypox Treatment market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Monkeypox Treatment market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Monkeypox Treatment, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Monkeypox Treatment market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Monkeypox Treatment market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Oral
Injectable
Market segment by Application
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
Global Monkeypox Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Bavarian Nordic
Chimerix, Inc.
CIDIC Company Limited
Emcure Pharmaceuticals
Emergent
Gilead Sciences Inc.
Hetero Drugs Limited
Jinan Jinda Pharmaceutical Chemistry Co. Ltd.
Mylan N.V.
Olon S.p.A.
Piramal Pharma Solutions
SIGA Technologies Inc.
Sonofi SA
Teva Pharmaceutical Industries Limited
Outline of Major Chapters:
Chapter 1: Introduces the definition of Monkeypox Treatment, market overview.
Chapter 2: Global Monkeypox Treatment market size in revenue.
Chapter 3: Detailed analysis of Monkeypox Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Monkeypox Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Monkeypox Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Monkeypox Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Monkeypox Treatment Overall Market Size
2.1 Global Monkeypox Treatment Market Size: 2022 VS 2029
2.2 Global Monkeypox Treatment Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Monkeypox Treatment Players in Global Market
3.2 Top Global Monkeypox Treatment Companies Ranked by Revenue
3.3 Global Monkeypox Treatment Revenue by Companies
3.4 Top 3 and Top 5 Monkeypox Treatment Companies in Global Market, by Revenue in 2022
3.5 Global Companies Monkeypox Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Monkeypox Treatment Players in Global Market
3.6.1 List of Global Tier 1 Monkeypox Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Monkeypox Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Monkeypox Treatment Market Size Markets, 2022 & 2029
4.1.2 Oral
4.1.3 Injectable
4.2 By Type – Global Monkeypox Treatment Revenue & Forecasts
4.2.1 By Type – Global Monkeypox Treatment Revenue, 2018-2023
4.2.2 By Type – Global Monkeypox Treatment Revenue, 2024-2029
4.2.3 By Type – Global Monkeypox Treatment Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Monkeypox Treatment Market Size, 2022 & 2029
5.1.2 Hospital Pharmacy
5.1.3 Online Pharmacy
5.1.4 Retail Pharmacy
5.2 By Application – Global Monkeypox Treatment Revenue & Forecasts
5.2.1 By Application – Global Monkeypox Treatment Revenue, 2018-2023
5.2.2 By Application – Global Monkeypox Treatment Revenue, 2024-2029
5.2.3 By Application – Global Monkeypox Treatment Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Monkeypox Treatment Market Size, 2022 & 2029
6.2 By Region – Global Monkeypox Treatment Revenue & Forecasts
6.2.1 By Region – Global Monkeypox Treatment Revenue, 2018-2023
6.2.2 By Region – Global Monkeypox Treatment Revenue, 2024-2029
6.2.3 By Region – Global Monkeypox Treatment Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Monkeypox Treatment Revenue, 2018-2029
6.3.2 US Monkeypox Treatment Market Size, 2018-2029
6.3.3 Canada Monkeypox Treatment Market Size, 2018-2029
6.3.4 Mexico Monkeypox Treatment Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Monkeypox Treatment Revenue, 2018-2029
6.4.2 Germany Monkeypox Treatment Market Size, 2018-2029
6.4.3 France Monkeypox Treatment Market Size, 2018-2029
6.4.4 U.K. Monkeypox Treatment Market Size, 2018-2029
6.4.5 Italy Monkeypox Treatment Market Size, 2018-2029
6.4.6 Russia Monkeypox Treatment Market Size, 2018-2029
6.4.7 Nordic Countries Monkeypox Treatment Market Size, 2018-2029
6.4.8 Benelux Monkeypox Treatment Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Monkeypox Treatment Revenue, 2018-2029
6.5.2 China Monkeypox Treatment Market Size, 2018-2029
6.5.3 Japan Monkeypox Treatment Market Size, 2018-2029
6.5.4 South Korea Monkeypox Treatment Market Size, 2018-2029
6.5.5 Southeast Asia Monkeypox Treatment Market Size, 2018-2029
6.5.6 India Monkeypox Treatment Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Monkeypox Treatment Revenue, 2018-2029
6.6.2 Brazil Monkeypox Treatment Market Size, 2018-2029
6.6.3 Argentina Monkeypox Treatment Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Monkeypox Treatment Revenue, 2018-2029
6.7.2 Turkey Monkeypox Treatment Market Size, 2018-2029
6.7.3 Israel Monkeypox Treatment Market Size, 2018-2029
6.7.4 Saudi Arabia Monkeypox Treatment Market Size, 2018-2029
6.7.5 UAE Monkeypox Treatment Market Size, 2018-2029
7 Monkeypox Treatment Companies Profiles
7.1 Bavarian Nordic
7.1.1 Bavarian Nordic Company Summary
7.1.2 Bavarian Nordic Business Overview
7.1.3 Bavarian Nordic Monkeypox Treatment Major Product Offerings
7.1.4 Bavarian Nordic Monkeypox Treatment Revenue in Global Market (2018-2023)
7.1.5 Bavarian Nordic Key News & Latest Developments
7.2 Chimerix, Inc.
7.2.1 Chimerix, Inc. Company Summary
7.2.2 Chimerix, Inc. Business Overview
7.2.3 Chimerix, Inc. Monkeypox Treatment Major Product Offerings
7.2.4 Chimerix, Inc. Monkeypox Treatment Revenue in Global Market (2018-2023)
7.2.5 Chimerix, Inc. Key News & Latest Developments
7.3 CIDIC Company Limited
7.3.1 CIDIC Company Limited Company Summary
7.3.2 CIDIC Company Limited Business Overview
7.3.3 CIDIC Company Limited Monkeypox Treatment Major Product Offerings
7.3.4 CIDIC Company Limited Monkeypox Treatment Revenue in Global Market (2018-2023)
7.3.5 CIDIC Company Limited Key News & Latest Developments
7.4 Emcure Pharmaceuticals
7.4.1 Emcure Pharmaceuticals Company Summary
7.4.2 Emcure Pharmaceuticals Business Overview
7.4.3 Emcure Pharmaceuticals Monkeypox Treatment Major Product Offerings
7.4.4 Emcure Pharmaceuticals Monkeypox Treatment Revenue in Global Market (2018-2023)
7.4.5 Emcure Pharmaceuticals Key News & Latest Developments
7.5 Emergent
7.5.1 Emergent Company Summary
7.5.2 Emergent Business Overview
7.5.3 Emergent Monkeypox Treatment Major Product Offerings
7.5.4 Emergent Monkeypox Treatment Revenue in Global Market (2018-2023)
7.5.5 Emergent Key News & Latest Developments
7.6 Gilead Sciences Inc.
7.6.1 Gilead Sciences Inc. Company Summary
7.6.2 Gilead Sciences Inc. Business Overview
7.6.3 Gilead Sciences Inc. Monkeypox Treatment Major Product Offerings
7.6.4 Gilead Sciences Inc. Monkeypox Treatment Revenue in Global Market (2018-2023)
7.6.5 Gilead Sciences Inc. Key News & Latest Developments
7.7 Hetero Drugs Limited
7.7.1 Hetero Drugs Limited Company Summary
7.7.2 Hetero Drugs Limited Business Overview
7.7.3 Hetero Drugs Limited Monkeypox Treatment Major Product Offerings
7.7.4 Hetero Drugs Limited Monkeypox Treatment Revenue in Global Market (2018-2023)
7.7.5 Hetero Drugs Limited Key News & Latest Developments
7.8 Jinan Jinda Pharmaceutical Chemistry Co. Ltd.
7.8.1 Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Company Summary
7.8.2 Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Business Overview
7.8.3 Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Monkeypox Treatment Major Product Offerings
7.8.4 Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Monkeypox Treatment Revenue in Global Market (2018-2023)
7.8.5 Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Key News & Latest Developments
7.9 Mylan N.V.
7.9.1 Mylan N.V. Company Summary
7.9.2 Mylan N.V. Business Overview
7.9.3 Mylan N.V. Monkeypox Treatment Major Product Offerings
7.9.4 Mylan N.V. Monkeypox Treatment Revenue in Global Market (2018-2023)
7.9.5 Mylan N.V. Key News & Latest Developments
7.10 Olon S.p.A.
7.10.1 Olon S.p.A. Company Summary
7.10.2 Olon S.p.A. Business Overview
7.10.3 Olon S.p.A. Monkeypox Treatment Major Product Offerings
7.10.4 Olon S.p.A. Monkeypox Treatment Revenue in Global Market (2018-2023)
7.10.5 Olon S.p.A. Key News & Latest Developments
7.11 Piramal Pharma Solutions
7.11.1 Piramal Pharma Solutions Company Summary
7.11.2 Piramal Pharma Solutions Business Overview
7.11.3 Piramal Pharma Solutions Monkeypox Treatment Major Product Offerings
7.11.4 Piramal Pharma Solutions Monkeypox Treatment Revenue in Global Market (2018-2023)
7.11.5 Piramal Pharma Solutions Key News & Latest Developments
7.12 SIGA Technologies Inc.
7.12.1 SIGA Technologies Inc. Company Summary
7.12.2 SIGA Technologies Inc. Business Overview
7.12.3 SIGA Technologies Inc. Monkeypox Treatment Major Product Offerings
7.12.4 SIGA Technologies Inc. Monkeypox Treatment Revenue in Global Market (2018-2023)
7.12.5 SIGA Technologies Inc. Key News & Latest Developments
7.13 Sonofi SA
7.13.1 Sonofi SA Company Summary
7.13.2 Sonofi SA Business Overview
7.13.3 Sonofi SA Monkeypox Treatment Major Product Offerings
7.13.4 Sonofi SA Monkeypox Treatment Revenue in Global Market (2018-2023)
7.13.5 Sonofi SA Key News & Latest Developments
7.14 Teva Pharmaceutical Industries Limited
7.14.1 Teva Pharmaceutical Industries Limited Company Summary
7.14.2 Teva Pharmaceutical Industries Limited Business Overview
7.14.3 Teva Pharmaceutical Industries Limited Monkeypox Treatment Major Product Offerings
7.14.4 Teva Pharmaceutical Industries Limited Monkeypox Treatment Revenue in Global Market (2018-2023)
7.14.5 Teva Pharmaceutical Industries Limited Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
